No Data
No Data
Express News | Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verastem Is Maintained at Outperform by RBC Capital
Verastem Price Target Raised to $16.00/Share From $13.00 by RBC Capital
Verastem Analyst Ratings
RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Raises Target Price to $16
Holy Cow 151170498 : No resistance for tonight. it's going only up up Up . Big news behind the scene